IOSP (Innospec) Cyclically Adjusted PS Ratio: 1.11 (As of Jul. 13, 2026) — 38% Below Median


IOSP Innospec Inc IOSP
76 GF Score
Price $82.08
GF Value $94.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Innospec Cyclically Adjusted PS Ratio?

Innospec IOSP +0.56% 76 Cyclically Adjusted PS Ratio is 1.11 as of Jul. 13, 2026, which is 38% below its 10-year median of 1.78. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,279 Chemicals companies, Innospec ranks better than 55.67% on this metric.

As of today (2026-07-13), Innospec's current share price is $82.08. Innospec's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $74.19. Innospec's Cyclically Adjusted PS Ratio for today is 1.11.

The historical rank and industry rank for Innospec's Cyclically Adjusted PS Ratio or its related term are showing as below:

IOSP' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.91   Med: 1.78   Max: 2.38
Current: 1.1

During the past years, Innospec's highest Cyclically Adjusted PS Ratio was 2.38. The lowest was 0.91. And the median was 1.78.

IOSP's Cyclically Adjusted PS Ratio is ranked better than
55.67% of 1279 companies
in the Chemicals industry
Industry Median: 1.32 vs IOSP: 1.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Innospec's adjusted revenue per share data for the three months ended in Mar. 2026 was $18.242. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $74.19 for the trailing ten years ended in Mar. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


Innospec  (NAS:IOSP) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Innospec Cyclically Adjusted PS Ratio Related Terms


Innospec Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Innospec's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec Cyclically Adjusted PS Ratio Chart

Innospec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.73 1.73 1.90 1.60 1.06

Innospec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.18 1.07 1.06 0.98

IOSP vs MTX, ODC, NGVT: Cyclically Adjusted PS Ratio Comparison

For the Specialty Chemicals subindustry, Innospec's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innospec Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innospec's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Innospec's Cyclically Adjusted PS Ratio falls into.


IOSP
76GF Score
Innospec Inc IOSP
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innospec Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Innospec's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=82.08/74.19
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Innospec's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=18.242/330.2130*330.2130
=18.242

Current CPI (Mar. 2026) = 330.2130.

Innospec Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 9.328 241.018 12.780
201609 8.396 241.428 11.484
201612 9.753 241.432 13.339
201703 11.999 243.801 16.252
201706 13.289 244.955 17.914
201709 13.531 246.819 18.103
201712 14.598 246.524 19.554
201803 14.678 249.554 19.422
201806 14.562 251.989 19.082
201809 14.762 252.439 19.310
201812 16.010 251.233 21.043
201903 15.788 254.202 20.509
201906 14.685 256.143 18.932
201909 15.048 256.759 19.353
201912 15.746 256.974 20.234
202003 15.047 258.115 19.250
202006 9.970 257.797 12.771
202009 10.724 260.280 13.605
202012 12.511 260.474 15.861
202103 13.671 264.877 17.043
202106 14.255 271.696 17.325
202109 15.126 274.310 18.209
202112 16.661 278.802 19.733
202203 18.929 287.504 21.741
202206 18.726 296.311 20.869
202209 20.549 296.808 22.862
202212 20.428 296.797 22.728
202303 20.415 301.836 22.334
202306 19.231 305.109 20.813
202309 18.560 307.789 19.912
202312 19.719 306.746 21.228
202403 19.955 312.332 21.097
202406 17.333 314.175 18.218
202409 17.665 315.301 18.500
202412 18.548 315.605 19.407
202503 17.560 319.799 18.132
202506 17.559 322.561 17.976
202509 17.741 324.800 18.037
202512 18.344 324.054 18.693
202603 18.242 330.213 18.242

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PS Ratio of 1.11 mean?
Innospec (IOSP) has a Cyclically Adjusted PS Ratio of 1.11 as of Jul. 13, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Innospec and its competitors. This is 38% below median its historical median of 1.78. Over the past decade, Innospec's Cyclically Adjusted PS Ratio has ranged from 0.91 to 2.38. According to the industry distribution chart, Innospec ranks #567 out of 1279 companies in the Chemicals industry, placing it in the top 44.3%.
Is Innospec's Cyclically Adjusted PS Ratio too high?
Innospec's current Cyclically Adjusted PS Ratio of 1.11 is 38% below median its 10-year median of 1.78. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 2.38. The Chemicals industry median Cyclically Adjusted PS Ratio is 1.32. Innospec's value of 1.11 is 15.9% below this industry median. Based on the distribution chart, Innospec ranks #567 out of 1279 companies in the Chemicals industry, which is above the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's Cyclically Adjusted PS Ratio compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #567 out of 1279 companies for Cyclically Adjusted PS Ratio. This puts Innospec in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.32. Innospec's value of 1.11 is 15.9% below this benchmark. Historically, Innospec's own Cyclically Adjusted PS Ratio has ranged from 0.91 to 2.38 over the past decade. While the company's 10-year median is 1.78 vs. the industry median of 1.32, Innospec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Chemicals company?
The median Cyclically Adjusted PS Ratio among Chemicals companies is 1.32, based on 1,279 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innospec's current Cyclically Adjusted PS Ratio of 1.11 is 15.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Innospec and its competitors. For the Chemicals industry, the median Cyclically Adjusted PS Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current Cyclically Adjusted PS Ratio is 1.11, which is 38% below median its own 10-year median of 1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.91, compared to a current price of $82.08 — trading 13.5% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.11, which is 38% below median its 10-year median of 1.78 and 15.9% below the Chemicals industry median of 1.32. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Innospec (IOSP), the current Cyclically Adjusted PS Ratio is 1.11 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innospec (IOSP) Overvalued in 2026?

Based on GuruFocus' analysis, Innospec stock appears to be undervalued. The current stock price of $82.08 is trading 13.5% below its estimated GF Value™ of $94.91. GuruFocus considers Innospec to be Modestly Undervalued.

Key valuation signals for IOSP:

  • Cyclically Adjusted PS Ratio: 1.11 (38% below median its 10-year median of 1.78)
  • GF Value™: $94.91 vs. price of $82.08 (13.5% below fair value)
  • GF Score™: 76/100 with 3 warning signs
  • Industry Position: 15.9% below the Chemicals median (#567 of 1279)

No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innospec Business Description

Other Exchanges 0JAX:UKOCT:Germany
Address 8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score

Get the complete analysis for IOSP

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.08
Price
$94.91
GF Value